Longeveron INC Form 4 insider transactions

Longeveron's Chief Medical Officer, Nataliya Agafonova, sold 6,120 shares of Class A Common Stock to cover tax obligations related to a restricted stock unit vesting.

Longeveron's CEO, Mohamed Wa'el Ahmed Hashad, sold 10,827 shares of Class A Common Stock to cover tax obligations related to a restricted stock unit vesting.

Longeveron's Chief Financial Officer, Lisa Locklear, sold 6,120 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Paul T. Lehr, General Counsel and Secretary of Longeveron Inc., reports the disposal of 1,205 shares to cover tax obligations related to vesting restricted stock units.

A Longeveron Inc. director, Khoso Baluch, sold 1,250 shares of Class A Common Stock at $2.0705 per share, following a correction of a previous filing error regarding a stock split.

Lisa Locklear, CFO of Longeveron Inc., reports the disposal of 5,316 shares to cover tax obligations related to vesting restricted stock units.

Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Paul T. Lehr, General Counsel and Secretary of Longeveron Inc., reports disposition of shares to cover tax obligations related to vesting of restricted stock units.

Longeveron's CEO, Mohamed Hashad, reports a transaction involving the withholding of shares to cover tax obligations related to a restricted stock unit award.

Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., reports acquisition of restricted stock units and stock options, as well as shares withheld for tax obligations.

Lisa Locklear, CFO of Longeveron Inc., reports the acquisition of 174,750 shares of Class A Common Stock and disposal of 14,035 shares to cover tax obligations.

Longeveron CEO Mohamed Hashad reported the acquisition of 311,250 shares of Class A Common Stock through a restricted stock unit (RSU) award and the disposal of 39,248 shares to cover tax obligations.

General Counsel and Secretary Paul T. Lehr reports acquisition of restricted stock units and stock options, as well as shares withheld for tax obligations.

Director and Chief Scientific Officer Joshua Hare reports acquisition of shares and stock options in Longeveron Inc.

Director Baluch Khoso reports acquisition of 23,500 shares of Longeveron Inc. through restricted stock units.

Ursula Ungaro, a director at Longeveron Inc., received 23,500 shares of Class A Common Stock on August 15, 2024, as part of a time-based vesting Restricted Stock Unit (RSU) award.

Director Rock Soffer was awarded 23,500 Restricted Stock Units (RSUs) in Longeveron Inc. on August 15, 2024.

Director Neil E. Hare reports acquisition of 23,500 shares of Longeveron Inc. Class A Common Stock through a Restricted Stock Unit (RSU) award.

Director Roger Joseph Hajjar acquired 16,000 shares of Longeveron Inc. common stock on July 2, 2024, as part of a restricted stock unit grant.

Director Neha J. Motwani acquired 16,000 shares of Longeveron Inc. Class A Common Stock on July 2, 2024, as part of a restricted stock unit grant.

Lisa Locklear, CFO of Longeveron Inc., disposed of 357 shares of Class A Common Stock on July 1, 2024, to satisfy tax obligations.

Director Khoso Baluch reports a transaction involving the withholding of shares to cover tax obligations related to a restricted stock unit vesting.

Paul T. Lehr, General Counsel and Secretary of Longeveron Inc., reports disposition of shares to cover tax obligations related to vesting of restricted stock units.

Director Richard N. Kender acquired 16,000 shares of Longeveron Inc. Class A Common Stock on May 10, 2024, through a grant of restricted stock units.

Lisa Locklear, CFO of Longeveron Inc., reports the disposal of 410 shares of Class A Common Stock to cover tax obligations following a one-for-ten reverse stock split.

Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., reports disposition of shares to cover tax obligations following a reverse stock split.

Director and Chief Scientific Officer Joshua Hare reports acquisition of Longeveron Inc. shares and warrants, along with a transfer of shares to an ex-spouse.

Longeveron's CEO, Mohamed Hashad, purchased 10,638 shares of Class A Common Stock and warrants at $2.35 on April 11, 2024.

Director Soffer Rock acquired additional shares and warrants of Longeveron Inc. (LGVN) on April 10 and 11, 2024, increasing their beneficial ownership.

CEO Mohamed Wa'el Ahmed Hashad reports acquisition and disposal of Longeveron Inc. shares on March 12, 2024, according to a Form 4 filing.